Mark Willis

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horáková et al. · JAMA · 2019 · 511 citations · Full text

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

Katharine Harding, Owain Williams, Mark Willis et al. · JAMA Neurology · 2019 · 342 citations · Full text

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

Tomáš Kalinčík, J William L Brown, Neil P. Robertson et al. · The Lancet Neurology · 2017 · 157 citations · Full text

Disease Progression, Medicine, Systemic Treatment +9

<scp>COVID</scp> ‐19 Vaccine Response in People with Multiple Sclerosis

Emma Tallantyre, Nicola Vickaryous, Valerie Anderson et al. · Annals of Neurology · 2021 · 150 citations · Full text

Still no archaeological evidence that Neanderthals created Iberian cave art

Randall White, Gerhard Bosinski, Raphaëlle Bourrillon et al. · Journal of Human Evolution · 2019 · 141 citations · Full text

Prehistoric Archaeology, Art History, Iberian Cave Art +10